2013年度業績

1.原著論文

• PDZ-RhoGEF and LARG are essential for embryo development, and provide a link between thrombin and LPA receptors and Rho activation.
  Palmby TR, Simaan M, Li W, Szabo R, Lyons R, Martin D, Yagi H, Fukuhara S, Chikumi H, Galisteo R, Mukouyama Y, Bugge TH, Gutkind JS.
  J Biol Chem. 288(17):12232-43, 2013.
• Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: Implication of EGFR tyrosine kinase inhibitors.
  Ito S, Igishi T, Takata M, Mikelis CM, Ueda Y, Matsumoto S, Kodani M, Takeda K, Izumi H, Sakamoto T, Yamaguchi K, Makino H, Touge H, Chikumi H, Shimizu E.
  Int J Oncol. 2014 Jan 8. doi: 10.3892/ijo.2014.2249. [Epub ahead of print]
• The 6-minute pegboard and ring test is correlated with upper extremity activity of daily living in chronic obstructive pulmonary disease.
  Takeda K, Kawasaki Y, Yoshida K, Nishida Y, Harada T, Yamaguchi K, Ito S, Hashimoto K, Matsumoto S, Yamasaki A, Igishi T, Shimizu E.
  Int J Chron Obstruct Pulmon Dis. 2013;8:347-51.
• Acute aortic thrombosis during cisplatin based chemotherapy for gastric cancer.
  Ito S, Nakamura Y, Noumi T, Sasaki Y.
  Intern Med. 2013;52(9):973-5.